These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 16495475)
1. Haymaker gene expression in malignant and normal gynecologic tissues. Borowsky ME; Das B; Axiotis CA; Malka ES; Abulafia O; Norin AJ J Histochem Cytochem; 2006 Jul; 54(7):753-61. PubMed ID: 16495475 [TBL] [Abstract][Full Text] [Related]
2. Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix. Wu M; Gunning W; Ratnam M Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):775-82. PubMed ID: 10498396 [TBL] [Abstract][Full Text] [Related]
3. Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium. Onuma K; Dabbs DJ; Bhargava R Int J Gynecol Pathol; 2008 Jul; 27(3):418-25. PubMed ID: 18580321 [TBL] [Abstract][Full Text] [Related]
4. Müllerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancers. Bakkum-Gamez JN; Aletti G; Lewis KA; Keeney GL; Thomas BM; Navarro-Teulon I; Cliby WA Gynecol Oncol; 2008 Jan; 108(1):141-8. PubMed ID: 17988723 [TBL] [Abstract][Full Text] [Related]
5. Lipid-soluble antioxidants: beta-carotene and alpha-tocopherol levels in breast and gynecologic cancers. Palan PR; Goldberg GL; Basu J; Runowicz CD; Romney SL Gynecol Oncol; 1994 Oct; 55(1):72-7. PubMed ID: 7959271 [TBL] [Abstract][Full Text] [Related]
6. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. Bignotti E; Tassi RA; Calza S; Ravaggi A; Romani C; Rossi E; Falchetti M; Odicino FE; Pecorelli S; Santin AD Gynecol Oncol; 2006 Nov; 103(2):405-16. PubMed ID: 16725184 [TBL] [Abstract][Full Text] [Related]
7. Oviductal glycoprotein, a new differentiation-based indicator present in early ovarian epithelial neoplasia and cortical inclusion cysts. Woo MM; Gilks CB; Verhage HG; Longacre TA; Leung PC; Auersperg N Gynecol Oncol; 2004 May; 93(2):315-9. PubMed ID: 15099939 [TBL] [Abstract][Full Text] [Related]
8. Difference in target cell recognition of naive and activated human natural killer cells: role of Haymaker (p38.5) in tumoricidal activity. Das B; Mushnitsky R; Norin AJ Hum Immunol; 2005 Mar; 66(3):241-51. PubMed ID: 15784462 [TBL] [Abstract][Full Text] [Related]
9. TTF-1 expression in ovarian and uterine epithelial neoplasia and its potential significance, an immunohistochemical assessment with multiple monoclonal antibodies and different secondary detection systems. Zhang PJ; Gao HG; Pasha TL; Litzky L; Livolsi VA Int J Gynecol Pathol; 2009 Jan; 28(1):10-8. PubMed ID: 19047914 [TBL] [Abstract][Full Text] [Related]
10. Cellular binding proteins for vitamin A in human carcinomas and in normal tissues. Palan PR; Romney SL Cancer Res; 1980 Nov; 40(11):4221-4. PubMed ID: 6258773 [TBL] [Abstract][Full Text] [Related]
11. Coexpression of cholesterol sulfate and cytokeratin as tumor markers in well-differentiated squamous cell carcinoma of the human uterine cervix. Kiguchi K; Iwamori M; Yamanouchi S; Ishiwata I; Saga M; Amemiya A Clin Cancer Res; 1998 Dec; 4(12):2985-90. PubMed ID: 9865910 [TBL] [Abstract][Full Text] [Related]
12. Human calmodulin-like protein (CLP) expression in oral squamous mucosa and in malignant transformation. Brooks MD; Bennett RD; Strehler EE; Sebo TJ; Eckert SE; Carr AB J Prosthodont; 2009 Jan; 18(1):11-6. PubMed ID: 19166543 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy. Kioi M; Kawakami M; Shimamura T; Husain SR; Puri RK Cancer; 2006 Sep; 107(6):1407-18. PubMed ID: 16902988 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of mammaglobin B in epithelial ovarian carcinomas. Tassi RA; Bignotti E; Rossi E; Falchetti M; Donzelli C; Calza S; Ravaggi A; Bandiera E; Pecorelli S; Santin AD Gynecol Oncol; 2007 Jun; 105(3):578-85. PubMed ID: 17343903 [TBL] [Abstract][Full Text] [Related]
15. Myogenic markers in the evaluation of embryonal botryoid rhabdomyosarcoma of the female genital tract. Riedlinger WF; Kozakewich HP; Vargas SO Pediatr Dev Pathol; 2005; 8(4):427-34. PubMed ID: 16220232 [TBL] [Abstract][Full Text] [Related]
16. Myogenic markers in the evaluation of embryonal botryoid rhabdomyosarcoma of the female genital tract. Riedlinger WF; Kozakewich HP; Vargas SO Pediatr Dev Pathol; 2005; 8(3):355-61. PubMed ID: 16010486 [TBL] [Abstract][Full Text] [Related]
17. Expression of the human copper influx transporter 1 in normal and malignant human tissues. Holzer AK; Varki NM; Le QT; Gibson MA; Naredi P; Howell SB J Histochem Cytochem; 2006 Sep; 54(9):1041-9. PubMed ID: 16709730 [TBL] [Abstract][Full Text] [Related]
18. RUNX3 protein is overexpressed in human epithelial ovarian cancer. Nevadunsky NS; Barbieri JS; Kwong J; Merritt MA; Welch WR; Berkowitz RS; Mok SC Gynecol Oncol; 2009 Feb; 112(2):325-30. PubMed ID: 18937968 [TBL] [Abstract][Full Text] [Related]
19. [Progress in the study on correlation of expression of survivin gene and gynecologic tumors]. Deng KX; Zhong L Zhonghua Fu Chan Ke Za Zhi; 2004 Aug; 39(8):566-8. PubMed ID: 15363365 [No Abstract] [Full Text] [Related]
20. Prostate-derived Ets factor is overexpressed in serous epithelial ovarian tumors. Rodabaugh KJ; Mhawech-Fauceglia P; Groth J; Lele S; Sood AK Int J Gynecol Pathol; 2007 Jan; 26(1):10-5. PubMed ID: 17197890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]